Similarly, in malignant mesothelioma (MM) cells, YAP/TEAD activates CD44 transcription by binding to the CD44 promoter at TEAD-binding sites, while CD44 regulates Merlin phosphorylation and sequentially promotes YAP transcriptional co-activator [34]. This evidence concerns the gene YAP1 and Miyoshi myopathy.